NCT00389987View on ClinicalTrials.gov

Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037)

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions
Complicated Intra-Abdominal Infections
Interventions
DRUG

MK0826, /Duration of Treatment : 8 Weeks

DRUG

Comparator : piperacillin sodium (+) tazobactam sodium /Duration of Treatment : 8 Weeks

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00389987 - Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037) | Biotech Hunter | Biotech Hunter